RT Journal Article
SR Electronic
T1 The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.04.20243949
DO 10.1101/2020.12.04.20243949
A1 Babu, Giridhara R
A1 Sundaresan, Rajesh
A1 Athreya, Siva
A1 Akhtar, Jawaid
A1 Pandey, Pankaj Kumar
A1 Maroor, Parimala S
A1 Padma, MR
A1 Lalitha, R
A1 Shariff, Mohammed
A1 Krishnappa, Lalitha
A1 Manjunath, CN
A1 Sudarshan, MK
A1 Gururaj, G
A1 Ranganath, TS
A1 Kumar, Vasanth
A1 Banandur, Pradeep
A1 Deepa, R
A1 Shiju, Shilpa
A1 Lobo, Eunice
A1 Satapathy, Asish
A1 Alahari, Lokesh
A1 Prameela,
A1 Vinitha, T
A1 Desai, Anita
A1 Ravi, V
YR 2020
UL http://medrxiv.org/content/early/2020/12/11/2020.12.04.20243949.abstract
AB Background Globally, the routinely used case-based reporting and IgG serosurveys underestimate the actual prevalence of COVID-19. Simultaneous estimation of IgG antibodies and active SARS-CoV-2 markers can provide a more accurate estimation.Methods A cross-sectional survey of 16416 people covering all risk groups was done between 3-16 September 2020 using the state of Karnataka’s infrastructure of 290 hospitals across all 30 districts. All participants were subjected to simultaneous detection of SARS-CoV-2 IgG using a commercial ELISA kit, SARS-CoV-2 antigen using a rapid antigen detection test (RAT), and reverse transcription-polymerase chain reaction (RT-PCR) for RNA detection. Maximum-likelihood estimation was used for joint estimation of the adjusted IgG, active, and total prevalence, while multinomial regression identified predictors.Findings The overall adjusted prevalence of COVID-19 in Karnataka was 27 ·3% (95% CI: 25 ·7-28 ·9), including IgG 16 ·4% (95% CI: 15 ·1 - 17 ·7) and active infection 12 ·7% (95% CI: 11 ·5-13 ·9). The case-to-infection ratio was 1:40, and the infection fatality rate was 0 ·05%. Influenza-like symptoms or contact with a COVID-19 positive patient are good predictors of active infection. The RAT kits had higher sensitivity (68%) in symptomatic participants compared to 47% in asymptomatic.Interpretation This is the first comprehensive survey providing accurate estimates of the COVID-19 burden anywhere in the world. Further, our findings provide a reasonable approximation of population immunity threshold levels. Using the RAT kits and following the syndromic approach can be useful in screening and monitoring COVID-19. Leveraging existing surveillance platforms, coupled with appropriate methods and sampling framework, renders our model replicable in other settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Health Mission, Government of Karnataka.The funding agency had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Ethics Committee (IEC) of the Indian Institute of Public Health-Bengaluru campus reviewed and approved the study (vide. IIPHHB/TRCIEC/174/2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are accessible to researchers upon formal request for data addressed to the Commissioner, Health and Family Welfare Services, Government of Karnataka.